According to HIA statistics, the US hearing aid market has experienced sales gains of 5.9% and may exceed 4 million hearing aid units dispensed by the end of 2018. Here’s a summary of the US hearing industry statistics through the third quarter of this year, including a look at the most-common styles of hearing aids sold.
Read More
For the 2018 third quarter, the company reported net sales of $30.1 million, up 20.2% from $25.1 million in the prior-year period. According to the announcement, the increase was primarily due to year-over-year revenue gains from IntriCon’s largest medical customer and growth in its value-based hearing healthcare business.
Read More
On October 5, the FDA granted De Novo status to Bose Corporation for a self-fitting hearing aid for mild-to-moderate hearing loss.
Read More
Shennib brings over 30 years of experience in healthcare innovations, starting his career in implantable cardiac pacing, and later taking leading roles with several hearing aid manufacturers including ReSound and InSound Medical, where he invented and developed the Lyric™ hearing device.
Read More
The 2018 Academy of Doctors of Audiology (ADA) Convention had the theme, “Bolder than Ever,” and lived up to it with 3 days of excellent seminars and events in Orlando, Fla, on October 22-24.
Read More
The Zounds product portfolio featured on Walmart.com includes the Vizara, a 16-Channel digital rechargeable hearing system; the Prezia, a 16-Channel premium digital hearing aid, and the Hearing in a Box digital RIC hearing aid.
Read More
Before jumping to the conclusion that any PSAP and/or future OTC hearing device would be suitable for the many different types of hearing losses, we need to look at their coupler and real-ear performance data. This study by Adam Voss, Kristi Oeding, AU Bankaitis, John Pumford, and Michael Valente suggests current PSAPs are suitable for mild losses only.
Read More
The FDA has concluded that the Bose Hearing Aid should be classified as a Class II device under the generic name “self-fitting air-conduction hearing aid,” according to an October 5 letter from the Agency. Accordingly, Bose is free to market the device immediately subject to general provisions and special controls required by FDA. Subsequent applications for a self-fitting hearing aid will need to undergo premarket notification requirements, according to the Agency.
Read More
Shares of three large hearing aid companies—GN Store Nord A/S, William Demant Holding A/S, and Sonova Holding AG—dropped significantly on Monday, according to an article on ‘Bloomberg.’
Read More
Shares of three large hearing aid companies—GN Store Nord A/S, William Demant Holding A/S, and Sonova Holding AG—dropped significantly on Monday, according to an article on ‘Bloomberg.’
Read More
The FDA’s recent granting of de novo status for the self-fit Bose Hearing Aid may open the door to a new era of hearing aid technology and dispensing. Unlike an “OTC hearing device,” there will likely be a “self-fitting category” within the current FDA Class I and Class II hearing aid classifications.
Read More
The FDA has approved the Bose Hearing Aid as the first self-fit hearing aid under the Agency’s De Novo premarket review pathway used for some low- to moderate-risk devices that are novel and for which there is no prior legally marketed device.
Read More
The typical image of a musician with hearing loss is someone like Beethoven, who lost his hearing long after spending a lifetime learning, playing, or composing aural music. What is lost in this image is the fact that there are individuals like myself, who acquire significant hearing loss shortly after birth or in early adolescence, yet fall in love with aural music during this same period in their lives.
Read More
A 35-year hiatus from music due to hearing loss, and a new beginning due to dedication.
Read More
Using Bluetooth technology in MFi-compatible hearing aids to create your own IEM system.
Read More